Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Jan Gettemans

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

ORCID iD: 0000-0001-6979-8872

Show Sort by

Add to list
- Journal Article
- A1
- open access
Alzheimer’s disease : a systems view provides a unifying explanation of its development

Corlia Grobler, Marvi van Tongeren (UGent) , Jan Gettemans (UGent) , Douglas B. Kell and Etheresia Pretorius

(2023) JOURNAL OF ALZHEIMERS DISEASE. 91(1). p.43-70
Add to list
- Journal Article
- A1
- open access
Nanobodies for accurate recognition of iso-tenuazonic acid and development of sensitive immunoassay for contaminant detection in foods

Feng Wang, Yuan-Yuan Yang, De-Bin Wan, Jia-Dong Li, Yi-Fan Liang, Zhen-Feng Li, Yu-Dong Shen, Zhen-Lin Xu, Jin-Yi Yang, Hong Wang, et al.

(2022) FOOD CONTROL. 136.
Add to list
- Journal Article
- A1
- open access
Nuclear fascin regulates cancer cell survival

Campbell D Lawson, Samantha Peel, Asier Jayo, Adam Corrigan, Preeti Iyer, Mabel Baxter Dalrymple, Richard J Marsh, Susan Cox, Isabel Van Audenhove (UGent) , Jan Gettemans (UGent) , et al.

(2022) ELIFE. 11.
Add to list
- Journal Article
- A1
- open access
Triazolinedione protein modification : from an overlooked off-target effect to a tryptophan-based bioconjugation strategy

Klaas Decoene, Kamil Ünal (UGent) , An Staes (UGent) , Olivier Zwaenepoel (UGent) , Jan Gettemans (UGent) , Kris Gevaert (UGent) , Johan Winne (UGent) and Annemieke Madder (UGent)

(2022) CHEMICAL SCIENCE. 13(18). p.5390-5397
Add to list
- Book Chapter
Site-specific fluorescent labeling, single-step immunocytochemistry, and delivery of nanobodies into living cells

Jan Gettemans (UGent)

(2022) Single-domain antibodies : methods and protocols. In Methods in Molecular Biology p.373-393
Add to list
Enhanced non-toxic immunodetection of Alternaria mycotoxin tenuazonic acid based on ferritin-displayed anti-idiotypic nanobody-nanoluciferase multimers

Feng Wang, Zhen-Feng Li, De-Bin Wan, Natalia Vasylieva, Yu-Dong Shen, Zhen-Lin Xu, Jin-Yi Yang, Jan Gettemans (UGent) , Hong Wang, Bruce D. Hammock, et al.

(2021) JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. 69(16). p.4911-4917
Add to list
- Journal Article
- A1
- open access
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells

Tijs Merckaert (UGent) , Olivier Zwaenepoel (UGent) , Kris Gevaert (UGent) and Jan Gettemans (UGent)

(2021) BIOMEDICINE & PHARMACOTHERAPY. 133.
Add to list
- Journal Article
- A1
- open access
Transforming nanobodies into high precision tools for protein function analysis

Jan Gettemans (UGent) and Brian De Dobbelaer (UGent)

(2021) AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 320(2). p.C195-C215
Add to list
- Journal Article
- A1
- open access
α-Actinin-4 promotes the progression of prostate cancer through the Akt/GSK-3β/β-catenin signaling pathway

Sungyeon Park, Minsoo Kang, Suhyun Kim, Hyoung-Tae An, Jan Gettemans (UGent) and Jesang Ko

(2020) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 8.
Add to list
- Journal Article
- A1
- open access
Development and characterization of protein kinase B/AKT isoform-specific nanobodies

Tijs Merckaert (UGent) , Olivier Zwaenepoel (UGent) , Kris Gevaert (UGent) and Jan Gettemans (UGent)

(2020) PLOS ONE. 15(10).

1
2
3
4
…
10
11

Next →